INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Operating Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Operating Profit (Excl OI) | ₹99 Cr | ₹236 Cr | ₹286 Cr | ₹326 Cr | ₹218 Cr |
What is the latest Operating Profit of INDOCO REMEDIES ?
Year | Operating Profit |
---|---|
Mar2025 | ₹99 Cr |
Mar2024 | ₹236 Cr |
Mar2023 | ₹286 Cr |
Mar2022 | ₹326 Cr |
Mar2021 | ₹218 Cr |
How is Operating Profit of INDOCO REMEDIES Trending?
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹99 Cr | -58.02 | |
Mar2024 | ₹236 Cr | -17.35 | |
Mar2023 | ₹286 Cr | -12.32 | |
Mar2022 | ₹326 Cr | 49.43 | |
Mar2021 | ₹218 Cr | - |
Compare Operating Profit of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹2,555.8 Cr | -2.3% | -12.5% | -22.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,002.0 Cr | -2.1% | -5.8% | -6.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹164,334.0 Cr | 3.1% | -6.5% | 28.7% | Stock Analytics | |
CIPLA | ₹127,613.0 Cr | 2.2% | 3.2% | 1.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,923.0 Cr | -1.7% | NA | 9.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,437.0 Cr | 1.4% | -1.1% | -7.6% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -2.3% |
-12.5% |
-22.2% |
SENSEX | -1.1% |
-1.7% |
-0.3% |
You may also like the below Video Courses